-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, affecting nearly 1% of the world's population
.
Current treatments for RA aim to achieve prolonged active periods and early and sustained remission of the disease through the gradual use of different drugs
Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, affecting nearly 1% of the world's population
In a study in Brazil, a new type of hydroxychloroquine and methotrexate co-loaded with Pluronic® F-127 nanomicelles was developed and its therapeutic effect on RA was evaluated
In this study, the researchers newly developed a new type of Pluronic® F-127 nanomicelles, the micelles are loaded with new hydroxychloroquine and methotrexate
.
Research results show that this drug-loaded nanomicelle can regulate the inflammatory process of RA and reduce osteoclast production, edema and cell migration to joints
In this study, the researchers newly developed a new type of Pluronic® F-127 nanomicelles, the micelles are loaded with new hydroxychloroquine and methotrexate
Nanomicelles are one of the most widely used nanoparticles, which can improve the blood circulation time, bioavailability and specificity of drugs
.
The therapeutic agent can be transported passively or actively after systemic administration, and selectively accumulate in the inflammation site.
Nanomicelles are one of the most widely used nanoparticles, which can improve the blood circulation time, bioavailability and specificity of drugs
Experimental contentExperimental content
Thirty-five C57BL/6 mice were divided into 7 experimental groups, each consisting of 5 animals
.
.
Animal handling
Animal handling animal handlingSham : 0.
1 mL saline and 0.
1 mL Freund's complete adjuvant
1 mL saline and 0.
1 mL Freund's complete adjuvant Sham
Saline:Equivalent normal saline
Saline:Equivalent saline SalinemBSA: 500 μg methylated bovine serum albumin (mBSA), 0.
1 mL saline and 0.
1 mL Freund’s complete adjuvant
.
1 mL saline and 0.
1 mL Freund’s complete adjuvant
.
mBSA:
Pluronic : 127-Pluronic
Pluronic : 127-Pluronic Pluronicintervention group 1 : 127-Pluronic−HCQ-MTX nanomicelles (2 mg / K and 1 mg / Kg, respectively);
intervention group 1 : 127-Pluronic−HCQ-MTX nanomicelles (2 mg / K and 1 mg / Kg, respectively); intervention group 1intervention group 2: 127-Pluronic−HCQ-MTX nanomicelles (1 mg / K and 0.
5 mg / Kg, respectively).
5 mg / Kg, respectively).
intervention group 2:
Experimental results
Experimental results Experimental results- In vitro drug release experiment:
- Osteoclastogenesis experiment
Expose monocytes in human peripheral blood to nanomicelles formed by the combination of two different concentrations of methotrexate and hydroxychloroquine (127-Pluronic-HCQ-MTX nanomicelles), 20 ug/mL HCQ and 074 ng/mL MTX and 70 ug/mL HCQ and 2.
6 ng/mL MTX
.
Four dilutions of nanomicelles (1:10, 1:100, 1:1000, and 1:2000) were tested in order to study a more effective concentration for RA treatment
Expose monocytes in human peripheral blood to nanomicelles formed by the combination of two different concentrations of methotrexate and hydroxychloroquine (127-Pluronic-HCQ-MTX nanomicelles), 20 ug/mL HCQ and 074 ng/mL MTX and 70 ug/mL HCQ and 2.
The results showed that the inhibition rate of MRP1 was 40-50%, proving that nanomicelles can improve the accumulation of drugs in cells
HCQ and MTX combined treatment of RA, compared with the current traditional way of administration, the lower dose of nanomicelle administration shows a better anti-inflammatory effect, and can be less drug-resistant
.
Original source: Tais Monteiro Magne, Edward Helal-Neto, Luana Barbosa Correa, et al.
Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results, Colloids and Surfaces B: Biointerfaces,
Volume 206,2021,111952,https ://doi.
org/10.
1016/j.
colsurfb.
2021.
111952.
Rheumatoid arthritis treatment using hydroxychloroquine and methotrexate co-loaded nanomicelles: In vivo results, Colloids and Surfaces B: Biointerfaces, et al.
Volume 206,2021, 111952, https://doi.
org/10.
1016/j.
colsurfb.
2021.
111952.
Leave a message here